BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Biotech Bay

  Guardant Health to Participate in the 2021 Stifel Healthcare Conference

  Guardant Health, Inc., a leading precision oncology company, announced the company will be participating virtually in the upcoming 2021 Stifel Healthcare Conference.

  November 8, 2021

   · 

  1 min read
• Business

  Castle Biosciences Announces Third Quarter 2021 Results

  Castle Biosciences, Inc., a company applying innovative diagnostics to inform disease management and improve patient outcomes, announced its financial results for the third quarter and nine months ended Sept. 30, 2021.

  November 8, 2021

   · 

  22 min read
• BioCapital

  Senseonics to Participate in Upcoming November 2021 Investor Conferences

  Senseonics Holdings, Inc., a medical technology company focused on the development and commercialization of long-term, implantable continuous glucose monitoring systems for people with diabetes, announced plans to participate in two upcoming investor conferences.

  November 8, 2021

   · 

  1 min read
• Business

  Amyris, Inc. Reports Third Quarter 2021 Financial Results

  Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world to sustainable consumption through its Lab-to-MarketTM operating platform, today announced financial results for its third quarter ended September 30, 2021.

  November 8, 2021

   · 

  24 min read
• Business

  AVEO Oncology Reports Third Quarter 2021 Financial Results and Provides Business Update

  AVEO Oncology, a commercial stage, oncology-focused biopharmaceutical company, reported financial results for the third quarter ended September 30, 2021 and provided a business update.

  November 8, 2021

   · 

  17 min read
• BioMidwest

  ANI Pharmaceuticals, Inc. Announces Closing of $75 Million Public Offering of Common Stock

  ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) (ANI or the Company) today announced the closing of its previously announced underwritten public offering.

  November 8, 2021

   · 

  2 min read
• Zymeworks to Present at Upcoming Investor Conferences - Nov 08, 2021

  Zymeworks Inc., a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, announced that management will participate in three upcoming investor conferences.

  November 8, 2021

   · 

  2 min read
• Genetown

  ProQR Announces Upcoming Investor Conferences in November and December

  ProQR Therapeutics N.V., a company dedicated to changing lives through the creation of transformative RNA therapies for genetic eye diseases, announced that Company management will participate in the following upcoming investor conferences

  November 8, 2021

   · 

  2 min read
• Deals

  MDxHealth Announces Completion of Initial Public Offering of ADSs in the United States

  MDxHealth Announces Completion of Initial Public Offering of ADSs in the United States

  November 8, 2021

   · 

  2 min read
• Business

  Nyxoah appoints new CFO

  Nyxoah SA, a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea, announced that Loïc Moreau will join Nyxoah as CFO as of January 1, 2022.

  November 8, 2021

   · 

  2 min read